Vaccination with a cocktail of seven recombinantly expressed HSV-1 glycoproteins protects against ocular HSV-1 challenge more efficiently than vaccination with any individual glycoprotein

Vaccine

Volumn 14, Issue 2, 1996, Pages 107-112

  Ghiasi, Homayon ^a,b   Nesburn, Anthony B ^a,b   Wechsler, Steven L ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glycoproteins; HSV 1; Latency; Mice; Ocular; Vaccine

Indexed keywords

HERPES SIMPLEX VACCINE; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; EYE DISEASE; FEMALE; HERPES SIMPLEX VIRUS 1; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION; VIRUS REPLICATION;

EID: 0030006278     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00169-2     Document Type: Article

References (38)

1. Little, S.P., Jofre, J.T., Courtney, R.J. and Schaffer, P.A. A virion associated glycoprotein essential for infectivity of herpes simplex virus type 1. Virology 1981, 115, 149-160
2. Cohen, G.H., Long, D. and Eisenberg, R.J. Synthesis and processing of glycoprotein gD and gC of herpes simplex virus type 1. J. Virol. 1980, 36, 429-439
3. Lee, G.T.Y., Para, M.F. and Spear, P.G. Location of the structural genes for glycoproteins gD and gE and for other polypeptides in the S component of Herpes Simplex Virus Type 1 DNA. J. Virol. 1982, 43, 41-49
4. Longnecker, R., Chatterjee, S., Whitley, R.J. and Roizman, B. Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture. Proc. Natl Acad. Sci. USA 1987, 84, 4303-4307
5. Frame, M.C., Marsden, H.S. and McGeoch, D.J. Novel herpes simplex virus type 1 glycoproteins identified by antiserum against a synthetic oligopeptide from the predicted product of gene US4. J. Gen. Virol. 1986, 67, 745-751
6. Buckmaster, E.A., Gompels, U. and Minson, A. Characterization and physical mapping of an HSV-1 glycoprotein of approximately 115,000 molecular weight. Virology 1984, 139, 408-413
7. Hutchinson, L., Goldsmith, K., Snoddy, D., Ghosh, H., Graham, F.L. and Johnson, D.C. Identification and characterization of a novel herpes simplex virus glycoprotein, gK, involved in cell fusion. J. Virol. 1992, 66, 5603-5609
8. Hutchinson, L., Browne, H., Wargent, V. et al. A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein-H (gH) and affects normal folding and surface expression of gH. J. Virol. 1992, 66, 2240-2250
9. McGeoch, D.J., Dalrymple, M.B., Davison, A.J. et al. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 1988, 69, 1531-1574
10. Baines, J.D. and Roizman, B. The UL10 gene of herpes simplex virus type 1 encodes a novel glycoprotein, gM, which is present in the virion and in the plasma membrane of infected cells. J. Virol. 1993, 67, 1441-1452
11. Norrild, B. Humoral response to herpes simplex virus infections. In: The Herpesviruses (Eds Roizman, B. and Lopez, C.). Plenum Press, New York, 1985, pp. 69-86
12. Long, D., Madara, T.J., Ponce de Leon, M., Cohen, G.H., Montgomery, P.C. and Eisenberg, R.J. Glycoprotein D protects mice against lethal challenge with Herpes Simplex Virus Types 1 and 2. Infect. Immun. 1984, 37, 761-764
13. Cantin, E.M., Eberle, R., Baldick, J.L. et al. Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proc. Natl Acad. Sci. USA 1987, 84, 5908-5912
14. Dix, R.D. Prospects for a vaccine against herpes simplex virus types 1 and 2. Prog. Med. Virol. 1987, 34, 89-128
15. Burke, R.L. Current developments in herpes simplex virus vaccines. Virology 1993, 4, 187-197
16. Eisenberg, R.J., Cerini, C.P., Heilman, C.J. et al. Synthetic glycoprotein D-related peptides protect mice against Herpes Simplex Virus challenge. J. Virol. 1985, 56, 1014-1017
17. Pachl, C., Burke, R.L., Stuve, L.L. et al. Expression of cell associated and secreted forms of herpes simplex virus type 1 glycoprotein gB in mammalian cells. J. Virol. 1987, 61, 315-325
18. Straus, S.E., Savarese, B., Tigges, M. et al. Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine. J. Infect. Dis. 1993, 167, 1045-1052
19. Paoletti, E., Lipinskas, B.R., Samsonoff, C., Mercer, S. and Panicali, D. Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. Proc. Natl Acad. Sci. USA 1984, 81, 193-197
20. Cremer, K.J., Mackett, M., Wohlenberg, C., Notkins, A.L. and Moss, B. Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science 1985, 228, 737-740
21. Martin, S. and Rouse, B.T. The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: viral clearance. J. Immunol. 1987, 138, 3431-3437
22. Stanberry, L.R., Bernstein, D.I., Burke, R.L., Pachl, C. and Myers, M.G. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes. J. Infect. Dis. 1987, 155, 914-920
23. Ghiasi, H., Kaiwar, R., Nesburn, A.B., Slanina, S. and Wechsler, S.L. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH and gI): comparative protection against lethal challenge in mice. J. Virol. 1994, 68, 2118-2126
24. Cantin, E.M., Willey, D.E., McLaughlin-Taylor, E., Eberle, R. and Openshaw, H. Immunization of mice with a vaccinia recombinant virus which expresses the glycoprotein B gene of herpes simplex virus type 1. In: Technological Advances in Vaccine Development. Alan R. Liss, Inc., New York, 1988, pp. 215-222
25. Lasky, L.A., Dowbenko, D., Simonsen, C.C. and Berman, P.W. Protection of mice from lethal herpes simplex virus infection by vaccination with a secreted form of cloned glycoprotein D. BioTechnology 1984, 4, 527-532
26. Stanberry, L.R., Harrison, C.J., Bernstein, D.I. et al. Herpes simplex virus glycoprotein immunotherapy of recurrent genital herpes: factors influencing efficacy. Antiviral Res. 1989, 11, 203-214
27. Stanberry, L.R., Myers, M.G., Stephanopoulos, D.E. and Burke, R.L. Preinfection prophylaxis with herpes simplex virus glycoprotein immunogens: factors influencing efficacy. J. Gen. Virol. 1989, 70, 3177-3185
28. Wechsler, S.L., Nesburn, A.B., Watson, R.J., Slanina, S.M. and Ghiasi, H. Fine mapping of the latency related gene of herpes simplex virus type 1: alternative splicing produces distinct latency related-RNAs containing open reading frames. J. Virol. 1988, 62, 4051-4058
29. Ghiasi, H., Kaiwar, R., Nesburn, A.B. and Wechsler, S.L. Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D. Arch. Virol. 1991, 121, 163-178
30. Ghiasi, H., Nesburn, A.B. and Wechsler, S.L. Cell surface expression of herpes simplex virus type-1 glycoprotein H in recombinant baculovirus infected cells. Virology 1991, 185, 187-194
31. Ghiasi, H., Kaiwar, R., Nesburn, A.B. and Wechsler, S.L. Expression of glycoprotein B of herpes simplex virus type 1 in insect cells: analysis of its biochemical and immunological properties. Virus Res. 1992, 22, 25-39
32. Ghiasi, H., Kaiwar, R., Nesburn, A.B. and Wechsler, S.L. Expression of herpes simplex virus type 1 (HSV-1) of glycoprotein I (gI) in baculovirus: preliminary biochemical, characterization and protection studies. J. Virol. 1992, 66, 2505-2509
33. Ghiasi, H., Kaiwar, R., Nesburn, A.B. and Wechsler, S.L. Baculovirus expressed glycoprotein H (gH) of Herpes simplex virus type 1 (HSV-1) induces neutralizing antibody and delayed hypersensitivity responses but does not protect immunized mice against lethal HSV-1 challenge. J. Gen. Virol. 1992, 73, 719-722
34. Ghiasi, H., Kaiwar, R., Nesburn, A.B. and Wechsler, S.L. Baculovirus expressed herpes simplex virus type I glycoprotein C protects mice from lethal HSV-1 infection. Antiviral Res. 1992, 18, 291-302
35. Ghiasi, H., Kaiwar, R., Nesburn, A.B. and Wechsler, S.L. Baculovirus expressed glycoprotein E (gE) of herpes simplex virus type-1 (HSV-1) protects mice against lethal intraperitoneal and lethal ocular HSV-1 challenge. Virology 1992, 188, 469-476
36. Ghiasi, H., Kaiwar, R., Nesburn, A.B. and Wechsler, S.L. Baculovirus expressed glycoprotein G of herpes simplex virus type I partially protects vaccinated mice against lethal HSV-1 challenge. Virology 1992, 190, 233-239
37. Nesburn, A.B., Ghiasi, H. and Wechsler, S.L. Ocular safety and efficacy of an HSV-1 gD vaccine during primary and latent infection. Invest. Ophthalmol. Vis. Sci. 1990, 31, 77-82
38. Ghiasi, H., Bahri, S., Nesburn, A.B. and Wechsler, S.L. Protection against HSV induced eye disease following vaccination with 7 individually expressed HSV-1 glycoproteins. Invest. Ophthalmol. Vis. Sci. 1995, 36, 1352-1360